Clinical Trial Update: Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether 18F-FDG-PET-CT improves risk stratification and guides treatment decisions for patients with muscle-invasive blad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Muscle-Invasive Bladder Carcinoma | Phase 2 | Status: RECRUITING